Papers

13

Total Citations

146

H-Index

7

About

A. Ruffion is a leading urological surgeon whose research centers on advancing minimally invasive surgical techniques for prostate and kidney cancers, with a particular focus on robot-assisted procedures and enhanced recovery protocols. His landmark nationwide analyses have fundamentally shaped the understanding of radical prostatectomy outcomes, demonstrating in a 2021 study (28 citations) the comparative costs and postoperative results across open, laparoscopic, and robotic approaches. Ruffion has been instrumental in evaluating novel therapeutic sequences, notably showing the feasibility of radical prostatectomy following vascular targeted photodynamic therapy with padeliporfin (26 citations), and pioneering same-day-discharge robot-assisted radical prostatectomy through comprehensive French national data (19 citations). His work extends to salvage procedures for recurrent prostate cancer, systematic reviews for the French ccAFU, and enhanced recovery after robot-assisted partial nephrectomy. With multiple high-impact publications tracking the nationwide evolution of prostate cancer surgery over five years, Ruffion's contributions provide essential evidence for optimizing surgical care, reducing hospital stays, and improving patient outcomes in urologic oncology.

Research Focus

Key Achievements

7
H-Index
13
Papers
146
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic)
28 citations · 2021
📈 Most Prolific Year: 2021 (4 Papers)
🤝 Key Collaborators: 111
🏛 Institutions: Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Hôpital Lyon Sud

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago